Secukinumab-induced ulcerative colitis: opening Pandora's box of immunity
Gastroenterol Hepatol. 2020 Aug-Sep;43(7):358-359.
doi: 10.1016/j.gastrohep.2019.12.004.
Epub 2020 Jun 17.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Medicina Digestiva. Hospital Universitari i Politècnic La Fe, Valencia, España. Electronic address: [email protected].
- 2 Servicio de Medicina Digestiva. Hospital Universitari i Politècnic La Fe, Valencia, España.
- 3 Servicio de Medicina Digestiva. Hospital Universitari i Politècnic La Fe, Valencia, España; Unidad de Enfermedad Inflamatoria Intestinal - Instituto de Investigación Sanitaria La Fe, Valencia, España; CIBERehd, Madrid, España.
No abstract available
MeSH terms
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Colitis, Ulcerative / chemically induced*
-
Colitis, Ulcerative / immunology
-
Humans
-
Male
-
Middle Aged
-
Psoriasis / drug therapy
Substances
-
Antibodies, Monoclonal, Humanized
-
secukinumab